Stay updated on Inhaled Treprostinil in PH-COPD Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.

Latest updates to the Inhaled Treprostinil in PH-COPD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov record for the inhaled treprostinil extension study is displayed instead of an error page, with detailed study information and posted results.SummaryDifference57%

- Check20 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces NIH updates and FAQs about using “Super Intelligence” in place of “Artificial Intelligence” across NIH content during a transition.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record content. This indicates access is blocked for this record, resulting in an error-state page rather than the study details.SummaryDifference17%

Stay in the know with updates to Inhaled Treprostinil in PH-COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.